Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis

Medicine and Dentistry

• Systemic Scleroderma 100%
• Patient 60%
• Association 46%
• Odds Ratio 40%
• Antibody 40%
• Genotype 33%
• Hispanic 26%
• Computed Tomography 26%
• Single Nucleotide Polymorphism 13%
• Topoisomerase 13%
• Ethnic Groups 6%
• Logistic Regression Analysis 6%
• Case-Control Study 6%
• Autoimmune Disease 6%
• Gene Frequency 6%
• Pyrosequencing 6%
• Gene 6%
• Assay 6%
• Race 6%

Immunology and Microbiology

• Systemic Scleroderma 100%
• Association 46%
• Monospecific Antibody 40%
• Centromere Antibody 40%
• Genotype 33%
• Single Nucleotide Polymorphism 13%
• Autoimmune Disease 6%
• Classification 6%
• Gene Frequency 6%
• Allele 6%
• Spectrum 6%
• Gene 6%
• Race 6%

Neuroscience

• Antibodies 40%
• Centromere Antibody 40%
• Polymorphism 20%
• Single-Nucleotide Polymorphism 13%
• Topoisomerase 13%
• Regression Analysis 6%
• Autoimmune Disease 6%
• Allele Frequency 6%
• Gene 6%
• Pyrosequencing 6%